Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Subscribe To Our Newsletter & Stay Updated
